Literature DB >> 29458963

B-Cell Metabolic Remodeling and Cancer.

Davide G Franchina1, Melanie Grusdat1, Dirk Brenner2.   

Abstract

Cells of the immune system display varying metabolic profiles to fulfill their functions. B lymphocytes overcome fluctuating energy challenges as they transition from the resting state and recirculation to activation, rapid proliferation, and massive antibody production. Only through a controlled interplay between metabolism, extracellular stimuli, and intracellular signaling can successful humoral responses be mounted. Alterations to this balance can promote malignant transformation of B cells. The metabolic control of B-cell fate is only partially understood. Here, we provide a compelling overview of the current state of the art and describe the main metabolic features of B cells during normal development and oncogenesis, with emphasis on the major B-cell transcriptional and metabolic regulators, including myelocytomatosis virus oncogene cellular homolog (Myc) and hypoxia-inducible factor 1-α (HIF-1α).
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  B cell; HIF-1α; Myc; immunometabolism; lymphoma

Mesh:

Year:  2018        PMID: 29458963     DOI: 10.1016/j.trecan.2017.12.006

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  16 in total

Review 1.  From zero to sixty and back to zero again: the metabolic life of B cells.

Authors:  Munir Akkaya; Susan K Pierce
Journal:  Curr Opin Immunol       Date:  2018-10-09       Impact factor: 7.486

2.  Lipid Metabolism in Tumor-Associated B Cells.

Authors:  Fan Yang; Fang Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Immunoglobulin expression in the endoplasmic reticulum shapes the metabolic fitness of B lymphocytes.

Authors:  Huda Jumaa; Marieta Caganova; Ellen J McAllister; Laura Hoenig; Xiaocui He; Deniz Saltukoglu; Kathrin Brenker; Markus Köhler; Ruth Leben; Anja E Hauser; Raluca Niesner; Klaus Rajewsky; Michael Reth; Julia Jellusova
Journal:  Life Sci Alliance       Date:  2020-04-27

4.  DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms Tumor.

Authors:  Fucai Tang; Zeguang Lu; Hanqi Lei; Yongchang Lai; Zechao Lu; Zhibiao Li; Zhicheng Tang; Jiahao Zhang; Zhaohui He
Journal:  Front Cell Dev Biol       Date:  2021-12-24

Review 5.  Metabolic Program of Regulatory B Lymphocytes and Influence in the Control of Malignant and Autoimmune Situations.

Authors:  Cristian Iperi; Anne Bordron; Maryvonne Dueymes; Jacques-Olivier Pers; Christophe Jamin
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

Review 6.  Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review.

Authors:  Lihui Liu; Chao Wang; Sini Li; Hua Bai; Jie Wang
Journal:  Transl Lung Cancer Res       Date:  2021-09

Review 7.  Supplying the trip to antibody production-nutrients, signaling, and the programming of cellular metabolism in the mature B lineage.

Authors:  Mark R Boothby; Shawna K Brookens; Ariel L Raybuck; Sung Hoon Cho
Journal:  Cell Mol Immunol       Date:  2021-11-15       Impact factor: 22.096

Review 8.  Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Authors:  Tiffany R Butterfield; Alan L Landay; Joshua J Anzinger
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071

Review 9.  Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy.

Authors:  Michael F Coleman; Alyssa J Cozzo; Alexander J Pfeil; Suhas K Etigunta; Stephen D Hursting
Journal:  Cancers (Basel)       Date:  2020-04-01       Impact factor: 6.639

Review 10.  Cellular based immunotherapy for primary liver cancer.

Authors:  Yuanyuan Zheng; Yan Li; Jiao Feng; Jingjing Li; Jie Ji; Liwei Wu; Qiang Yu; Weiqi Dai; Jianye Wu; Yingqun Zhou; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.